X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs AUROBINDO PHARMA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD AUROBINDO PHARMA STRIDES SHASUN LTD/
AUROBINDO PHARMA
 
P/E (TTM) x 14.5 18.5 78.2% View Chart
P/BV x 2.0 6.0 32.6% View Chart
Dividend Yield % 0.5 0.3 154.3%  

Financials

 STRIDES SHASUN LTD   AUROBINDO PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
AUROBINDO PHARMA
Mar-16
STRIDES SHASUN LTD/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,4131,541 91.7%   
Low Rs848582 145.7%   
Sales per share (Unadj.) Rs353.3237.5 148.8%  
Earnings per share (Unadj.) Rs23.433.9 69.0%  
Cash flow per share (Unadj.) Rs41.040.6 101.0%  
Dividends per share (Unadj.) Rs5.002.50 200.0%  
Dividend yield (eoy) %0.40.2 187.8%  
Book value per share (Unadj.) Rs320.4120.6 265.7%  
Shares outstanding (eoy) m89.35585.17 15.3%   
Bonus/Rights/Conversions ESOPPREF-  
Price / Sales ratio x3.24.5 71.6%   
Avg P/E ratio x48.331.3 154.3%  
P/CF ratio (eoy) x27.626.2 105.4%  
Price / Book Value ratio x3.58.8 40.1%  
Dividend payout %21.47.4 289.7%   
Avg Mkt Cap Rs m100,988621,041 16.3%   
No. of employees `0004.713.3 35.3%   
Total wages/salary Rs m4,98815,508 32.2%   
Avg. sales/employee Rs Th6,730.010,457.6 64.4%   
Avg. wages/employee Rs Th1,063.61,167.1 91.1%   
Avg. net profit/employee Rs Th445.51,491.6 29.9%   
INCOME DATA
Net Sales Rs m31,564138,961 22.7%  
Other income Rs m1,2121,663 72.9%   
Total revenues Rs m32,776140,624 23.3%   
Gross profit Rs m5,21332,056 16.3%  
Depreciation Rs m1,5733,926 40.1%   
Interest Rs m1,8032,568 70.2%   
Profit before tax Rs m3,04927,225 11.2%   
Minority Interest Rs m12739 323.8%   
Prior Period Items Rs m-270-   
Extraordinary Inc (Exp) Rs m-3710-   
Tax Rs m6897,444 9.3%   
Profit after tax Rs m2,08919,820 10.5%  
Gross profit margin %16.523.1 71.6%  
Effective tax rate %22.627.3 82.6%   
Net profit margin %6.614.3 46.4%  
BALANCE SHEET DATA
Current assets Rs m35,949100,015 35.9%   
Current liabilities Rs m19,40274,759 26.0%   
Net working cap to sales %52.418.2 288.5%  
Current ratio x1.91.3 138.5%  
Inventory Days Days71107 66.0%  
Debtors Days Days127110 115.7%  
Net fixed assets Rs m34,47852,350 65.9%   
Share capital Rs m894585 152.7%   
"Free" reserves Rs m22,60167,707 33.4%   
Net worth Rs m28,63270,567 40.6%   
Long term debt Rs m27,4558,472 324.1%   
Total assets Rs m76,591156,994 48.8%  
Interest coverage x2.711.6 23.2%   
Debt to equity ratio x1.00.1 798.7%  
Sales to assets ratio x0.40.9 46.6%   
Return on assets %5.114.3 35.6%  
Return on equity %7.328.1 26.0%  
Return on capital %8.237.7 21.6%  
Exports to sales %48.151.0 94.3%   
Imports to sales %14.518.8 76.7%   
Exports (fob) Rs m15,19270,927 21.4%   
Imports (cif) Rs m4,56526,193 17.4%   
Fx inflow Rs m16,61271,015 23.4%   
Fx outflow Rs m5,29228,799 18.4%   
Net fx Rs m11,32042,216 26.8%   
CASH FLOW
From Operations Rs m71717,596 4.1%  
From Investments Rs m-22,284-13,801 161.5%  
From Financial Activity Rs m29,488-198 -14,870.1%  
Net Cashflow Rs m8,0733,597 224.4%  

Share Holding

Indian Promoters % 27.7 54.1 51.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 8.0 475.5%  
FIIs % 8.6 27.7 31.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 10.2 253.9%  
Shareholders   56,241 69,601 80.8%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  MERCK LTD  

Compare STRIDES SHASUN LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Lupin up 4%(01:30 pm)

After opening the day flat, share markets in India remained rangebound and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 24, 2017 02:23 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 5-YR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS